The BCL6 gene helps your cells switch other genes on and off at the right time, especially as immune cells grow and mature. If it does not work normally, cell behavior can become less controlled, which may affect development and may also let some white blood cells survive longer than they should, a change linked to certain lymphomas.
What is a gene?
A gene is a stretch of DNA that carries instructions your cells can use to make molecules or regulate processes in the body. Some genes hold the information needed to produce proteins, the parts of cells that do much of the work. Other genes mainly help determine when certain processes happen, where they occur, and how active they are. Together, genes affect how the body develops and works, and they can also influence how you respond to food, stress, or medications. To explore this topic further, you can learn more in the LearnHub.
Overview
BCL6Gene function
What if the gene works
The BCL6 gene helps control how certain immune cells grow and mature, especially B cells that make antibodies. It also helps these cells respond in a balanced way during infections.
Risk
What if the gene does not work
Changes in the BCL6 gene can disrupt control of B cells, most often contributing to certain lymphomas. Rare variants can also affect brain development, with effects ranging from mild learning difficulties to broader developmental delay.
Treatment
What does that mean for your treatment
No BCL6-specific treatment or management approach is currently established. In lymphoma research, changes involving the BCL6 gene are being studied as drug targets and as biomarkers, but they do not currently guide routine treatment choices in clinical guidelines.
Conditions associated with BCL6
Gene function
What if the gene works
In everyday immune activity, the BCL6 gene helps certain white blood cells stay organized and focused. It mainly acts as a gene controller, turning down selected instructions so immune cells can mature and work in a coordinated way. This is a key part of how the BCL6 gene helps B cells make better antibodies after meeting germs.
This gene turns down the activity of selected genes at specific times. That helps immune cells follow the right growth and development program.
In lymph nodes and the spleen, this gene helps B cells enter a focused training stage where antibodies are improved. It supports the rapid growth and selection that shape a more precise immune response.
During normal antibody improvement, B cells make planned DNA changes in their antibody genes. This gene helps these cells stay on task while that tightly controlled process is underway.
This gene also guides a group of helper T cells, another type of white blood cell, that work closely with B cells. These cells help B cells compare antibody options and support a strong, lasting immune response.
What is a variant?
A genetic variant is a small difference in the DNA sequence of a gene. These differences are common and help make up normal human diversity, such as variation in appearance, metabolism, or the way the body responds to environmental influences. Many variants do not have any noticeable effect and simply represent natural genetic variation. In some situations, though, a variant can change how a gene functions more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
How BCL6 gene variants affect protein function depends on the type of DNA change. Some variants lower the amount of BCL6 made, shorten the protein, or alter the part that binds DNA or partner proteins, so gene control becomes less precise; milder missense variants may leave partial activity, while more disruptive variants often cause a larger loss of function. In some cells, rearrangements can also keep the BCL6 gene too active, changing when target genes are turned off.
How variants are linked to conditions
Variants involving the BCL6 gene are most clearly linked to certain B cell cancers, especially diffuse large B cell lymphoma and some follicular lymphomas. In this setting, BCL6 gene variants and rearrangements are usually acquired in the cancer cells, not inherited through a family. Rare inherited BCL6 variants have been reported in research, but the broadest clinical agreement centers on its role in lymphoma.
A variant is not necessarily a diagnosis
Variants in genes are a usual feature of human biology and are widely found across the general population. Most do not directly affect health and instead represent part of normal human variation. For many genes, having a variant associated with a condition points to a possible link rather than a certain diagnosis, particularly when several genes and environmental influences contribute. In some situations, though, one well-understood variant in a particular gene is enough to establish a diagnosis.
Are there things that can increase or change my risk?
There is not yet broadly confirmed evidence on specific factors that increase or reduce health risk related to the BCL6 gene. Because BCL6 is most often discussed in cancer research rather than as a common inherited risk gene, personal risk is usually shaped by the wider medical picture, not this gene alone.
Inheritance of BCL6 variants
There is not yet a broadly confirmed, disease-specific inheritance pattern for the BCL6 gene, so the BCL6 inheritance pattern is still being clarified as research develops. The BCL6 gene is located on chromosome 3, which is an autosome, so each person inherits one copy from each parent. In general, that means a variant in BCL6 could be passed through either side of the family.
What does my BCL6 result mean for my family?
There is not yet a broadly confirmed inherited pattern linking BCL6 to a specific, well-defined genetic condition in families. If you have a BCL6 result and want to understand what it could mean for relatives, a genetics specialist can explain it in the context of your exact result and personal or family history.
Genetic information
Genetic testing
How you find out about variants
Genetic testing for BCL6 variants usually uses a blood sample, saliva, or a cheek swab. A lab reads the DNA in the BCL6 gene and checks for variants by comparing your sequence with the usual reference sequence. The report may identify a known disease causing variant, a benign finding, or a variant of uncertain significance.
When should I consider getting a genetic test?
There is not a broadly established reason for inherited BCL6 testing based on family history alone. BCL6 is more often checked in tumor testing when doctors are sorting out some lymph system cancers, especially lymphoma, and testing decisions are best made with your cancer team or a genetic counselor.
A genetic result is only one part of your health story
A genetic result can provide valuable insight, but the amount it reveals depends on the condition and the kind of variant involved. Over time, many factors, including lifestyle, environment, age, and medical history, influence how the body functions. For some conditions, particularly those shaped by many genes, genetic information offers context rather than certainty and is most useful when considered alongside other parts of care. In other situations, a genetic result can give a clear answer. In areas like medication response, genetic results can also help make sense of individual experiences.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. This helps explain why the same drug may work well for one person, have less effect in another, or cause more side effects in someone else. Differences in how the body breaks down, moves, or responds to a medication are common, and they can influence both treatment benefit and medicine sensitivity.
What is Pharmacogenetics?
Pharmacogenetics examines how differences in a person’s genes can affect the way they respond to medications. It studies gene-drug patterns to help explain why the same treatment may work differently in different people. For many medicines, genes can influence how much effect a drug has or how the body handles it. This information can support more informed, more personalized treatment choices. More detail on this topic is available in the LearnHub.
Drugs influenced by the BCL6 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medicine choice or dosing, so general medication questions are best discussed with your doctor. BCL6 is being studied in some blood cancers because its activity may affect how certain cancer cells respond to treatment, but this is not part of routine prescribing.
History
The BCL6 gene entered medical research through studies of certain B cell lymphomas in the early 1990s, when recurrent chromosome changes pointed scientists to a new cancer related gene on chromosome 3. First described in the scientific literature as part of early cancer genetics, it was linked especially to diffuse large B cell lymphoma. From these first observations, research expanded steadily, and BCL6 became an important marker in lymphoma classification and laboratory studies. Its discovery helped clarify why some lymphomas look similar under the microscope but behave differently in practice. Over time, descriptions became more precise as genetic testing and tumor profiling improved. Today, BCL6 remains a well known part of the history of modern lymphoma research.